Business description
Seagen Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union.
Management board & Supervisory board
CEO |
David R. Epstein |
Management board |
Felix J. Baker, Todd E. Simpson, Charles Romp, Jean I. Liu, Natasha Hernday, Roger D. Dansey, Vaughn B. Himes, Lee Heeson, Peggy Pinkston, Sherry Pudloski, Lu Chen, William Compton |
Supervisory board |
Alpna Seth, Daniel G. Welch, David W. Gryska, John A. Orwin, Nancy A. Simonian, Ted Love, Sandra M. Swain, David R. Epstein |
Company data
Name: |
Seagen Inc. |
Address: |
21717-30th Drive S.E., Building 3,Bothell, WA 98021, USA |
Phone: |
+1-425-527-4000 |
Fax: |
- |
E-mail: |
contact@seagen.com
|
Internet: |
https://www.seagen.com/ |
Industry: |
Biotechnology |
Sector: |
Biotechnology |
Sub sector: |
Biotechnology |
End of financial year: |
12-31 |
Free Float: |
- |
IPO date: |
2001-03-01 |
Investor relations
Name: |
Peggy Pinkston |
IR phone: |
+1-425-527-4160 |
IR Fax: |
- |
IR e-mail: |
investors@seagen.com
|